Aetna modified CPB 0708 for metatarsal phalangeal joint replacement, effective November 26, 2025. Here's what billing teams need to know.
Aetna, a CVS Health company, updated its metatarsal phalangeal joint replacement coverage policy under CPB 0708 in Aetna's clinical policy bulletin system. The policy draws a hard line between covered procedures—hemiarthroplasty and silastic total prosthetic replacement—and a long list of devices and approaches Aetna calls experimental or unproven. HCPCS codes L8641 and L8642 are central to reimbursement under this policy, and getting the device and diagnosis pairing right is where most claim denials will happen.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Metatarsal Phalangeal Joint Replacement |
| Policy Code | CPB 0708 |
| Change Type | Modified |
| Effective Date | November 26, 2025 |
| Impact Level | Medium |
| Specialties Affected | Orthopedic Surgery, Podiatry, Foot & Ankle Surgery |
| Key Action | Audit implant device selection and confirm it maps to L8641 or L8642 before billing; claims tied to excluded devices will deny regardless of diagnosis |
Aetna Metatarsal Phalangeal Joint Replacement Coverage Criteria and Medical Necessity Requirements 2025
Aetna's coverage policy for MTP joint replacement is narrow by design. The policy covers procedures only for patients with disabling arthritis of the first metatarsal phalangeal joint—what clinicians call hallux rigidus. That diagnosis maps to ICD-10 codes M20.20, M20.21, and M20.22.
Two procedure types meet Aetna's medical necessity standard. First, hemiarthroplasty of the first MTP joint. Second, total prosthetic replacement arthroplasty using silastic implants—specifically the In2Bones Reference Toe System (RTS) Implant and the Primus Flexible Great Toe Implant. Those are the only named devices Aetna considers medically necessary under this coverage policy. Everything else is on the exclusion list.
CPT 28291 (hallux rigidus correction with cheilectomy, debridement, and capsular release of the first metatarsophalangeal joint) is covered when selection criteria are met. HCPCS L8641 and L8642 are the device codes Aetna maps to the In2Bones RTS and Primus Flexible implants. If you're billing these codes, the implant documentation in the operative note must match one of those two named devices. Anything else and you're heading toward a claim denial.
The policy does not explicitly state prior authorization requirements within CPB 0708 itself, but Aetna MTP joint replacement billing for surgical implant procedures commonly triggers prior auth review under member benefit plans. Check the individual member's plan documents before scheduling. Assuming no prior auth is required because the policy doesn't mandate it is a costly mistake.
Aetna Metatarsal Phalangeal Joint Replacement Exclusions and Non-Covered Indications
This is where the policy gets detailed—and where your billing team needs to pay close attention. Aetna lists seven categories of excluded procedures and devices. Each one is considered experimental, investigational, or unproven because, in Aetna's words, "effectiveness and durability has not been established."
Here's the exclusion list in full. None of these will get covered under CPB 0708:
| # | Excluded Procedure |
|---|---|
| 1 | Accu-Joint Hemi Implant for MTP joint arthritis |
| 2 | Bioabsorbable poly-L-D-lactic acid RegJoint interositional implant for hallux rigidus and arthritic hallux valgus |
| 3 | Ceramic prostheses—including the Moje implant—for first MTP joint replacement and other indications |
| 4 | Interpositional arthroplasty with biologic spacers (e.g., the InterPhlex interdigital implant) and total prosthetic replacement using total metallic implants for hallux rigidus, degenerative arthritis, and other MTP indications |
| 5 | MTP joint replacement for indications not listed in Section I—meaning anything other than disabling hallux rigidus |
| 6 | Modular implants—a list that includes the Arthrex MTP joint implant, the Cartiva Synthetic Cartilage Implant, the METIS prosthesis, the OsteoMed ReFlexion 1st MTP Implant System, and the ToeFit-Plus prosthesis |
| 7 | Roto-Glide implant for avascular necrosis of the MTP joint |
The Cartiva Synthetic Cartilage Implant deserves a specific callout. It's widely used, and some practices still have it in their charge capture workflows from earlier periods when coverage was more ambiguous. Under this policy, it's explicitly experimental. If your surgeons still use Cartiva, claims to Aetna will deny under CPB 0708 as updated.
The METIS prosthesis and ToeFit-Plus prosthesis also get a second mention in the HCPCS code notes. HCPCS L8641 and L8642—while listed as covered device codes for the In2Bones RTS and Primus Flexible implants—are explicitly not covered when billed for the METIS or ToeFit-Plus. That's a nuance worth flagging in your charge capture system so the wrong device doesn't trigger an erroneous L8641 or L8642 claim.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Disabling hallux rigidus — hemiarthroplasty | Covered | CPT 28291, L8641, L8642, M20.20–M20.22 | Medical necessity requires hallux rigidus diagnosis |
| Disabling hallux rigidus — silastic total prosthetic replacement (In2Bones RTS or Primus Flexible) | Covered | L8641, L8642, M20.20–M20.22 | Named devices only; operative note must confirm device |
| Hallux rigidus — Cartiva Synthetic Cartilage Implant | Experimental | M20.20–M20.22 | Modular implant; explicitly excluded |
| Hallux rigidus — Arthrex MTP joint implant | Experimental | M20.20–M20.22 | Modular implant; explicitly excluded |
| Hallux rigidus — OsteoMed ReFlexion 1st MTP Implant System | Experimental | M20.20–M20.22 | Modular implant; explicitly excluded |
| Hallux rigidus — METIS or ToeFit-Plus prosthesis | Experimental | M20.20–M20.22 | L8641/L8642 explicitly not covered for these devices |
| Hallux rigidus — ceramic prostheses (e.g., Moje implant) | Experimental | M20.20–M20.22 | Not covered for any indication |
| Hallux valgus — any MTP joint replacement | Not Covered | M20.10–M20.12 | Not a listed covered indication under CPB 0708 |
| Avascular necrosis of MTP joint — Roto-Glide implant | Experimental | M87.71–M87.79 | Explicitly excluded; AVN not a covered indication |
| Interpositional arthroplasty with biologic spacers | Experimental | L8658 | InterPhlex and similar biologic spacers excluded |
| Total metallic implant arthroplasty | Experimental | — | Excluded for hallux rigidus and degenerative arthritis |
| Accu-Joint Hemi Implant | Experimental | — | Excluded for MTP arthritis |
| RegJoint bioabsorbable implant | Experimental | — | Excluded for hallux rigidus and arthritic hallux valgus |
Aetna Metatarsal Phalangeal Joint Replacement Billing Guidelines and Action Items 2025
This policy update has a clear financial exposure point: device-to-code mismatch. Get the implant documentation and HCPCS code aligned, or expect denials. Here are the specific steps your billing team should take.
| # | Action Item |
|---|---|
| 1 | Audit your charge capture for CPT 28291, L8641, and L8642 before billing any claims under the November 26, 2025 effective date. Confirm that the implant listed in the operative report is either the In2Bones RTS or the Primus Flexible. If it's any other device, the claim will deny under CPB 0708. |
| 2 | Remove Cartiva from any Aetna MTP billing workflows immediately. If your practice uses the Cartiva Synthetic Cartilage Implant and you've been billing it to Aetna, that path is closed under the updated coverage policy. Talk to your compliance officer about any outstanding claims or pending appeals tied to Cartiva. |
| 3 | Flag the METIS and ToeFit-Plus device exclusion in your billing system. HCPCS L8641 and L8642 are not covered when those devices are used. Build a hard stop or alert so those device-code combinations don't get submitted. |
| 4 | Verify diagnosis coding before submission. The covered indication is disabling arthritis of the first MTP joint—hallux rigidus. Use M20.20 (unspecified), M20.21 (right foot), or M20.22 (left foot) to match laterality. Hallux valgus codes M20.10–M20.12 do not support coverage under this policy, even though they're listed in the policy's ICD-10 table as related codes. |
| 5 | Check prior authorization requirements at the plan level before scheduling surgery. CPB 0708 doesn't call out PA explicitly, but individual Aetna plan benefits often require prior auth for surgical implant procedures. A missing PA approval is the fastest path to a claim denial on an otherwise clean claim. |
| 6 | For avascular necrosis cases (M87.71–M87.79), do not bill MTP joint replacement to Aetna. The Roto-Glide implant—the only device specifically associated with this indication—is experimental under CPB 0708. These cases won't meet medical necessity under the current policy. |
If your practice has a high volume of MTP surgeries and your surgeons use a mix of the approved and excluded devices, loop in your billing consultant now. The line between covered and excluded is entirely device-specific, and the reimbursement exposure across a full surgical schedule adds up fast.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Metatarsal Phalangeal Joint Replacement Under CPB 0708
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 28291 | CPT | Hallux rigidus correction with cheilectomy, debridement, and capsular release of the first metatarsophalangeal joint |
Other CPT Codes Related to CPB 0708
| Code | Type | Description |
|---|---|---|
| 26535 | CPT | Arthroplasty, interphalangeal joint; each joint |
| 26536 | CPT | Arthroplasty, interphalangeal joint; with prosthetic implant, each joint |
Covered HCPCS Device Codes (In2Bones RTS and Primus Flexible Implants Only)
| Code | Type | Description | Notes |
|---|---|---|---|
| L8641 | HCPCS | Metatarsal joint implant | Not covered for METIS® prosthesis or ToeFit-Plus™ prosthesis |
| L8642 | HCPCS | Hallux implant | Not covered for METIS® prosthesis or ToeFit-Plus™ prosthesis |
Other HCPCS Codes Related to CPB 0708
| Code | Type | Description |
|---|---|---|
| L8658 | HCPCS | Interphalangeal joint spacer, silicone or equal, each |
Key ICD-10-CM Diagnosis Codes
| Code | Description |
|---|---|
| M20.10 | Hallux valgus, unspecified foot |
| M20.11 | Hallux valgus, right foot |
| M20.12 | Hallux valgus, left foot |
| M20.20 | Hallux rigidus, unspecified foot |
| M20.21 | Hallux rigidus, right foot |
| M20.22 | Hallux rigidus, left foot |
| M87.71 | Idiopathic aseptic necrosis of ankle, foot and toes |
| M87.72 | Idiopathic aseptic necrosis of ankle, foot and toes |
| M87.73 | Idiopathic aseptic necrosis of ankle, foot and toes |
| M87.74 | Idiopathic aseptic necrosis of ankle, foot and toes |
| M87.75 | Idiopathic aseptic necrosis of ankle, foot and toes |
| M87.76 | Idiopathic aseptic necrosis of ankle, foot and toes |
| M87.77 | Idiopathic aseptic necrosis of ankle, foot and toes |
| M87.78 | Idiopathic aseptic necrosis of ankle, foot and toes |
| M87.79 | Idiopathic aseptic necrosis of ankle, foot and toes |
Get the Full Picture for CPT 28291
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.